IRD
Opus Genetics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.64
+0.76%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 31.47x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -29.69x
- Price / sales
- 39.12x
- Price / cash flow
- -9.48x
Enterprise value
- Enterprise value
- $331.7M
- EV / sales
- 33.66x
- EV / EBITDA
- -3.16x
- EV / EBIT
- -6.55x
- Market cap
- $385.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026